These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1328892)

  • 1. Cicletanine sulfate: inhibition of anion transport systems and natriuretic activity.
    Garay RP; Rosati C; Nazaret C; Esanu A; Tarrade T; Braquet P
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):114-9. PubMed ID: 1328892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for (+)-cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat.
    Garay RP; Rosati C; Fanous K; Allard M; Morin E; Lamiable D; Vistelle R
    Eur J Pharmacol; 1995 Feb; 274(1-3):175-80. PubMed ID: 7768271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the O-sulfo derivative of MK-447 as active metabolite of MK-447.
    Garay RP; Nazaret C; Cragoe EJ
    Eur J Pharmacol; 1991 Jul; 200(1):141-6. PubMed ID: 1663036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of cell growth factors and cicletanine sulfate on the sodium-independent [Cl-/HCO3-] exchange in cultured vascular smooth muscle.
    Fanous K; Nazaret C; Senn N; Decoopman-Morin E; Allard M; Garay RP
    Am J Hypertens; 1993 Aug; 6(8):674-9. PubMed ID: 8217030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Cl-/NaCO3- anion exchanger by xipamide in human red blood cells.
    Nazaret C; Diez J; Hannaert PA; Christen MO; Wierzbicki N; Garay RP
    Eur J Pharmacol; 1987 Dec; 144(3):353-62. PubMed ID: 3440481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cicletanine: new insights into its pharmacological actions.
    Kalinowski L; Szczepańska-Konkel M; Jankowski M; Angielski S
    Gen Pharmacol; 1999 Jul; 33(1):7-16. PubMed ID: 10428010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a sulfo-conjugate as active metabolite of cicletanine.
    Garay RP; Rosati C; Nazaret C; Esanu A; Berthet P; Tarrade T; Braquet P
    J Hypertens Suppl; 1991 Dec; 9(6):S342-3. PubMed ID: 1818992
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cicletanine on renal cGMP production.
    Valdivielso JM; Morales AI; Pérez-Barriocanal F; López-Novoa JM
    Can J Physiol Pharmacol; 1998 Dec; 76(12):1151-5. PubMed ID: 10326838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects.
    Moulin B; Fillastre JP; Godin M; Coquerel A; Decoopman E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):292-9. PubMed ID: 7752655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lack of effect of cicletanine and its sulfoconjugated metabolite on the thiazide receptor expressed in Xenopus oocytes].
    Monroy A; Plata C; Gamba G; Droy-Lefaix MT; Garay RP
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1001-4. PubMed ID: 10486654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by (-)-cicletanine of the vascular reactivity to angiotensin II and vasopressin in isolated rat vessels.
    Vargas F; Alvarez-Guerra M; Droy-Lefaix MT; Garay RP
    Am J Hypertens; 1998 May; 11(5):579-84. PubMed ID: 9633794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
    Garay RP; Labaune JP; Mesangeau D; Nazaret C; Imbert T; Moinet G
    J Pharmacol Exp Ther; 1990 Nov; 255(2):415-22. PubMed ID: 2243333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the relaxing effects of cicletanine and cromakalim on vascular smooth muscle.
    Deitmer P; Golenhofen K; Noack T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):35-42. PubMed ID: 1383629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of cicletanine on renal function in diabetic spontaneously hypertensive rats.
    Duran MJ; Sennoune S; Arnaud C; Garcia S; Droy-Lefaix MT; Maixent JM
    Cell Mol Biol (Noisy-le-grand); 2004 Nov; 50(7):869-74. PubMed ID: 15672472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanical stress increases sodium ion content in vascular smooth muscle cells through a calcium-dependent pathway: prevention by cicletanine via a cyclo-oxygenase product.
    Rosati C; Cavalier S; Braquet P; Berthet P; Tarrade T; Ruchoux MM; Garay R
    J Hypertens Suppl; 1989 Dec; 7(6):S322-3. PubMed ID: 2561148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cicletanine-induced decreases in cytosolic Ca2+ level and contraction in vascular smooth muscle.
    Izumi M; Mitsui-Saito M; Ozaki H; Karaki H
    Jpn J Pharmacol; 1998 Jan; 76(1):57-63. PubMed ID: 9517405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of cicletanine in the rat. Stereochemical aspects.
    Vistelle R; Lamiable D; Morin E; Trenque T; Kaltenbach M
    Drug Metab Dispos; 1995 Sep; 23(9):988-92. PubMed ID: 8565790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cicletanine on reperfusion-induced arrhythmias and myocardial ion contents: a comparison with furosemide.
    Koltai M; Tosaki A; Berthet P; Tarrade T; Esanu A; Braquet P
    Eur Heart J; 1992 Mar; 13(3):395-403. PubMed ID: 1597228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of muzolimine and other diuretics on human red cell Na+, K+-cotransport.
    Knorr A; Garthoff B; Ingendoh A; De Mendonça M
    Z Kardiol; 1985; 74 Suppl 2():175-8. PubMed ID: 4002796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.